Press release

Explore our most recent innovations : genERGY & genSPECTRA!

Grenoble: 15/04/18

Discover new tests from GENEL:
Compelling ways of analysing how mitochondria are boosted by an active ingredient and a unique method to study the effects of blue light!

 PDF

GENEL featured in the "Journal des Entreprises"

Grenoble: 09/06/17

GENEL was cited in the "Journal des Entreprises" as a contributor of the biotech hub of grenoble for our research in the oncology department! Read the article here!

 PDF

Sharing our pride over what the Press has to say about us!

Grenoble: 10/04/17

Annie Zylberberg from Présences Magazine has dedicated her piece to GENEL. Read the article below!

 PDF

Discover EXOgen

03/04/17

EXOgen is an innovative cell-based in vitro test that leverages exosome-based cell communication to reveal the actual effects of an active ingredient.
Take a look at our technical data sheet to learn more!

 PDF

Discover genDETOX

03/04/17

genDETOX is an integrated test which identifies the active ingredient with the highest ability to activate the detoxification response of the skin cell.
Learn more through our technical data sheet!

 PDF

Discover genPROTECT

03/04/17

genPROTECT is a panel of 3 innovative and complementary tests that assess the ability of your active ingredient to protect and repair the DNA.
Download our technical data sheet to learn more!

 PDF

Biocosmethic and Genel joined forces to develop a new approach for active ingredient positioning

Grenoble: 08/03/2017

ExoGEN which reveals the ability of an active ingredient to act remotely on its target via exosomal communication.

 PDF

L’épigénétique dans la mélanogenèse

Grenoble: 19/01/2016

Une tendance durable : avoir un teint lumineux et lisse. Comment faire pour que notre peau paraisse naturellement éclatante ?
La beauté du teint, preuve de bien-être et de bonne santé, est étroitement liée au processus de pigmentation des cellules de la peau : la mélanogénèse.
La mélanogénèse doit être finement régulée car, avec l'âge, des taches inestéthiques apparaissent. Ces défauts de pigmentation sont dus à de multiples facteurs tels que le stress, la surexposition au soleil, voire des problèmes hormonaux.
Les microARNs, petits brins d'acides ribonucléiques, ont été identifiés comme des acteurs clés du processus de pigmentation. Ils régulent l'expression des gènes impliqués dans la mélanogenèse et fournissent ainsi de nouvelles solutions visant à réduire ces désordres pigmentaires...

L'intégralité de l'article en suivant le lien ci-dessous:

 PDF

Genel, lauréate 2015 du Trophée R2B Onco

Lyon: 24/11/2015

Neolys Diagnostics (Lyon) et Genel (Grenoble), deux jeunes sociétés de biotechnologies, ont été récompensées le 24 novembre à Lyon du trophée R2B ONCO 2015. Remis conjointement par M. David KIMELFELD, Premier Vice-Président de la Métropole de Lyon en charge de l’économie et par les représentants des Sociétés d’Accélération de Transfert de Technologies Pulsalys et Linksium, cette récompense salue deux jeunes entreprises d’Auvergne Rhône-Alpes présentant un fort potentiel d’innovation et de valorisation dans le secteur de la cancérologie…

 PDF

BASF and GENEL highlight the implication of a microRNA in the melanogenesis process

Grenoble: 07/05/2015

Find the right microRNA involved in the melanogenesis process and give us a chance to fight skin pigmentation disorder

 PDF

Cell Based Assays, Phenotypic Screening and Pioneering Technologies

Berlin: 17/03/2015

Genel will attend Drug Discovery Innovations 2015, 17&18 March in Berlin.

Come and learn more about Novel Advances in Assay Development and Screening Technologies to Improve Lead Discovery and Increase In Vivo Translation and Reduce Attrition in Small Molecule Drug Discovery.

Come see us at the poster session. Contact [celine] to set up a meeting.

 PDF

Genel's Original Approach

Paris: 06/01/2015

Bulletins électroniques : Genel's Original Approach to Cancer and RNA Interference

 PDF

BlueSky Meeting 3rd edition

Lyon: 10/10/2014

8th edition of Lyonbiopole Partnering Days
The event is organized around two key moments : 20 Roundtables and The BlueSky Meeting.
The BlueSky Meeting will provide the opportunity for SMEs and project in the field of health to present their innovative technology offers and ideas of projects open to collaboration. Gaelle Saint-Auret will present GENEL’s innovation.
[contactus] to set up a meeting.

 PDF

GENEL Winner 2014

Paris: 01/07/2014

GENEL Winner 2014 of the 16th national competition for the creation of innovative companies

Since 1999, the national competition for the creation of innovative technology companies has led to the creation of 1,476 companies that have generated sustainable jobs. Springboard for young talent and innovation, it is the first device to boot France and ensures its successful role in detecting projects to create innovative companies.

The goal of this competition is to encourage entrepreneurship and better support the development of start-ups with innovative technologies spirit.
Funding for this competition is provided by the Ministry of Research and OSEO innovation.
Thanks to its high-level expertise, this competition has become a must-do to any innovative project leader.

As an acknowledgement of French research dynamism, but also of its creativity and innovation, the 2014 edition of this competition rewards GENEL by giving it partial financial support and the acknowledgement of the strength of its project.

 PDF

GENEL Winner 2014 of the Réseau Entreprendre Isère

Grenoble: 23/06/2014

Réseau Entreprendre supports GENEL's development. Supporting its business growth, helping its international expansion and creating new jobs will be the objectives of this 2-year partnership. Big thanks to the members of this network for their support in the marketing of our high-content screening approach.

 PDF